Northside Hospital Inc.- GCS/Athens — Athens, Georgia

Northside Hospital Inc.- GCS/Athens is a clinical research site located in Athens, Georgia, United States 30606.

Crixeo Clinical Trials Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

Northside Hospital Inc.- GCS/Athens has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: HER2-positive Breast Cancer, HER2 Positive Breast Cancer, Breast Neoplasms.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Athens

Browse all research sites in Georgia · View every site in Athens

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northside Hospital Inc.- GCS/Athens?

Northside Hospital Inc.- GCS/Athens has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northside Hospital Inc.- GCS/Athens conducted?

Northside Hospital Inc.- GCS/Athens has 4 clinical trials on record, with 1 currently active. Their work covers HER2-positive Breast Cancer, HER2 Positive Breast Cancer, Breast Neoplasms.

Is Northside Hospital Inc.- GCS/Athens accredited by Crixeo Clinical Trials?

Northside Hospital Inc.- GCS/Athens has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northside Hospital Inc.- GCS/Athens?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.